El-Saed Aiman, Al-Jardani Amina, Althaqafi Abdulhakeem, Alansari Huda, Alsalman Jameela, Al Maskari Zaina, El Gammal Ayman, Al Nasser Wafa, Al-Abri Seif S, Balkhy Hanan H
Infection Prevention and Control Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia; Gulf Cooperation Council States and World Health Organization Collaborating Center for Infection Prevention & Control, Saudi Arabia; Community Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Gulf Cooperation Council States and World Health Organization Collaborating Center for Infection Prevention & Control, Saudi Arabia; Infection Prevention and Control, Royal Hospital, Muscat, Oman.
Am J Infect Control. 2016 Jul 1;44(7):794-8. doi: 10.1016/j.ajic.2016.01.042. Epub 2016 Mar 31.
Data estimating the rates of ventilator-associated pneumonia (VAP) in critical patients in Gulf Cooperation Council (GCC) countries are very limited. The aim of this study was to estimate VAP rates in GCC hospitals and to compare rates with published reports of the U.S. National Healthcare Safety Network (NHSN) and International Nosocomial Infection Control Consortium (INICC).
VAP rates and ventilator utilization between 2008 and 2013 were calculated from aggregate VAP surveillance data using NHSN methodology pooled from 6 hospitals in 3 GCC countries: Saudi Arabia, Oman, and Bahrain. The standardized infection ratios of VAP in GCC hospitals were compared with published reports of the NHSN and INICC.
A total of 368 VAP events were diagnosed during a 6-year period covering 76,749 ventilator days and 134,994 patient days. The overall VAP rate was 4.8 per 1,000 ventilator days (95% confidence interval, 4.3-5.3), with an overall ventilator utilization of 0.57. The VAP rates showed a wide variability between different types of intensive care units (ICUs) and were decreasing over time. After adjusting for the differences in ICU type, the risk of VAP in GCC hospitals was 217% higher than NHSN hospitals and 69% lower than INICC hospitals.
The risk of VAP in ICU patients in GCC countries is higher than pooled U.S. VAP rates but lower than pooled rates from developing countries participating in the INICC.
关于海湾合作委员会(GCC)国家重症患者呼吸机相关性肺炎(VAP)发生率的数据非常有限。本研究的目的是估计海湾合作委员会国家医院的VAP发生率,并与美国国家医疗安全网络(NHSN)和国际医院感染控制协会(INICC)发表的报告中的发生率进行比较。
使用从沙特阿拉伯、阿曼和巴林这3个海湾合作委员会国家的6家医院汇总的NHSN方法,根据VAP监测汇总数据计算2008年至2013年期间的VAP发生率和呼吸机使用率。将海湾合作委员会国家医院VAP的标准化感染率与NHSN和INICC发表的报告进行比较。
在为期6年的时间里,共诊断出368例VAP事件,涵盖76,749个呼吸机日和134,994个患者日。总体VAP发生率为每1000个呼吸机日4.8例(95%置信区间,4.3 - 5.3),总体呼吸机使用率为0.57。不同类型的重症监护病房(ICU)之间的VAP发生率差异很大,且随时间下降。在调整ICU类型差异后,海湾合作委员会国家医院VAP的风险比NHSN医院高217%,比INICC医院低69%。
海湾合作委员会国家ICU患者发生VAP的风险高于美国汇总的VAP发生率,但低于参与INICC的发展中国家的汇总发生率。